With the development of WTO rules to prevent the availability of cheap generic drugs there is the opportunity to reduce the level of lost profit due to generic introduction as patents run out. Whilst this will aid Johnson and Johnson where they own the brand where they are looking to capitalise on introducing generic drugs to market this ruling will become a hindrance.
Read more: http://www.ukessays.com/essays/marketing/case-study-johnson-johnson-marketing-essay.php#ixzz3oAv7Jgqb